EU competition policy

Summary: EU Pharmaceutical Activity: Challenges Arising From The Pharmaceutical Strategy And Beyond

EUHealthGov started 2023 with its seventh quarterly seminar on 25th January – a roundtable on EU pharmaceutical activity which encompassed challenges from the much-awaited revisions to the EU pharmaceutical strategy and beyond. We were delighted to be joined by a range of experts to consider different aspects, notably solidarity and vulnerability in access to pharmaceuticals;

Summary: EU Pharmaceutical Activity: Challenges Arising From The Pharmaceutical Strategy And Beyond Read More »

Watch again: EU Pharmaceutical Activity: Challenges Arising From The Pharmaceutical Strategy And Beyond

In case you missed it: On 25th January, EUHealthGov started its 2023 activities with a webinar devoted to EU pharmaceutical activity hosted by Dr Mary Guy (LJMU). We were delighted to host Dr Éloïse Gennet (Aix-Marseille) and Dr Aurélie Mahalatchimy (Aix-Marseille), Professor Wolf Sauter (VU Amsterdam), and Dr Katrina Perehudoff (University of Amsterdam) in a

Watch again: EU Pharmaceutical Activity: Challenges Arising From The Pharmaceutical Strategy And Beyond Read More »

“Euro-ambivalence”, EU competition law, and national healthcare systems: How the UK parliament joined some of the dots with NHS reform

“We send the EU £350 million a week. Let’s fund our NHS instead” proved an effective – if misleading – slogan for the Leave campaign in the 2016 UK referendum on EU membership. While this may simply suggest a “very British” variety of Euroscepticism, its implications arguably prove further-reaching, with learning for other countries (and

“Euro-ambivalence”, EU competition law, and national healthcare systems: How the UK parliament joined some of the dots with NHS reform Read More »

Summary: EU Competition Policy and Healthcare: starter questions for future directions

EUHealthGov started 2022 with its third quarterly seminar on 12th January – a roundtable on EU competition policy in healthcare which aimed to identify future directions in light of the 2020 CJEU Dôvera judgment regarding private and state health insurance in Slovakia, and the Casa Regina Apostolorum case (currently on appeal to the CJEU) concerning

Summary: EU Competition Policy and Healthcare: starter questions for future directions Read More »

Watch again: EU Competition Policy and Healthcare: starter questions for future directions

In case you missed it, you can watch the recoding of our event ‘EU Competition Policy and Healthcare: Starter Questions for Future Directions’ here. On 12 January 2022, EUHealthGov held its third quarterly seminar. We were delighted to be joined by Professor Johan von der Gronden (Radboud University Nijmegen), Dr Bruno Nikolić (Ljubljana) and Dr

Watch again: EU Competition Policy and Healthcare: starter questions for future directions Read More »